Patents Assigned to Neopharm Co., Ltd.
-
Patent number: 11744791Abstract: Provided are a cosmetic composition for promoting lipid biosynthesis, a cosmetic composition for inducing differentiation of adipose precursor cells or stem cells into adipocytes, and a cosmetic composition for moisturizing the skin, all of which include an amide-based compound. The cosmetic composition according to the present invention can promote the lipid biosynthesis and can promote expression of PPAR-? and cluster of differentiation 44, which are markers for labeling human adipose tissue-derived stem cells, to promote differentiation of the adipose tissue-derived stem cells into mature adipocytes, thereby improving a decreased volume and an impaired function of an adipose tissue caused due to the involution of the adipose tissue and giving a synergistic effect to the expression of a skin moisturizing factor.Type: GrantFiled: March 11, 2021Date of Patent: September 5, 2023Assignee: Neopharm Co., Ltd.Inventors: Yoon Kim, Kyung Sook Yoo, Bu-Mahn Park, Yu Ra Jung, Hye Seong Shin
-
Patent number: 11607378Abstract: Provided is a cosmetic composition for protection of the skin against reactive oxygen species, ultraviolet rays, or blue light, which includes an amide-based compound. The cosmetic composition according to the present invention can effectively inhibit cell damage caused by the reactive oxygen species, the ultraviolet rays, or the blue light and protect the skin without irritating the skin, and can simultaneously aid in recovering the damaged skin.Type: GrantFiled: March 11, 2021Date of Patent: March 21, 2023Assignee: Neopharm Co., Ltd.Inventors: Yoon Kim, Kyung Sook Yoo, Bu-Mahn Park, Yu Ra Jung, Hye Seong Shin
-
Patent number: 11471391Abstract: Provided are a cosmetic composition for inhibiting sebum hypersecretion and a method of inhibiting sebum hypersecretion using the same. According to the present invention, there may be provided the cosmetic composition of inhibiting and adjusting sebum secretion which is harmless to the human body with excellent skin safety and decreases activity of peroxisome proliferator activated receptor gamma (PPAR-?) to fundamentally decrease sebum overproduction, thereby providing the skin with an effective effect, and a method of using the same.Type: GrantFiled: May 19, 2020Date of Patent: October 18, 2022Assignee: NeoPharm Co., Ltd.Inventors: Kyung Sook Yoo, Bu-Mahn Park, Min Hee Kim, Yu Ra Jung, Hye Seong Shin
-
Patent number: 11446223Abstract: The present invention relates to an anti-aging composition. More specifically, the anti-aging composition according to the present invention is highly stable, harmless to the body, and effective in reducing wrinkles and improving elasticity of the skin due to the superb capability for stimulating collagen biosynthesis.Type: GrantFiled: April 7, 2017Date of Patent: September 20, 2022Assignee: NEOPHARM CO., LTD.Inventors: Se Kyoo Jeong, Bu-Mahn Park, Kyung Sook Yoo, Sung Woo Kim, Hye Seong Shin
-
Patent number: 11351131Abstract: An anti-inflammatory composition is disclosed. The anti-inflammatory composition is useful for a pharmaceutical composition or a cosmetic composition by not only having excellent stability on the skin and therefore being harmless to the human body, but also by controlling the expression of an inflammatory skin disease-related mediating factor and thereby exhibiting an excellent anti-inflammatory effect.Type: GrantFiled: August 25, 2017Date of Patent: June 7, 2022Assignee: NEOPHARM CO., LTD.Inventors: Ji Yeon Park, Minhee Kim, Bu-Mahn Park, Kyung Sook Yoo, Sung Woo Kim, Hye Seong Shin
-
Patent number: 11345655Abstract: Provided are a novel pseudoceramide compound and a skin external composition comprising the same. The skin external composition comprising a pseudoceramide compound or a pharmaceutically acceptable salt or solvate thereof according to the present invention as an active ingredient has an excellent effect of improving a skin barrier function, thereby exhibiting an effect of improving inflammatory skin diseases, and also is excellent in the function of improving the skin barrier and the effect of enhancing skin moisture.Type: GrantFiled: October 15, 2019Date of Patent: May 31, 2022Assignee: NEOPHARM CO., LTD.Inventors: Bu-Mahn Park, Hye Seong Shin
-
Patent number: 11285119Abstract: An anti-inflammatory composition is disclosed. The anti-inflammatory composition is be useful for a pharmaceutical composition or a cosmetic composition by not only having excellent stability on the skin and therefore being harmless to the human body, but also by controlling the expression of an inflammatory skin disease-related mediating factor and thereby exhibiting an excellent anti-inflammatory effect.Type: GrantFiled: August 25, 2017Date of Patent: March 29, 2022Assignee: NEOPHARM CO., LTD.Inventors: Ji Yeon Park, Minhee Kim, Bu-Mahn Park, Kyung Sook Yoo, Sung Woo Kim, Hye Seong Shin
-
Patent number: 11161822Abstract: Provided are a novel amide compound and a use thereof. According to the present invention, there may be provided a use of a novel amide compound which is harmless to the human body with excellent skin stability and decreases activity of peroxisome proliferator activated receptor gamma (PPAR-?) to fundamentally inhibit sebum overproduction, thereby providing the skin with an effective effect, and a cosmetic composition including the same.Type: GrantFiled: May 19, 2020Date of Patent: November 2, 2021Assignee: NeoPharm Co., Ltd.Inventors: Kyung Sook Yoo, Bu-Mahn Park, Min Hee Kim, Yu Ra Jung, Hye Seong Shin
-
Patent number: 10695275Abstract: The present invention relates to an anti-aging composition. More specifically, the anti-aging composition according to the present invention is highly stable, harmless to the body, and effective in reducing wrinkles and improving elasticity of the skin due to the superb capability for stimulating collagen biosynthesis.Type: GrantFiled: April 7, 2017Date of Patent: June 30, 2020Assignee: NEOPHARM CO., LTD.Inventors: Se Kyoo Jeong, Bu-Mahn Park, Kyung Sook Yoo, Sung Woo Kim, Hye Seong Shin
-
Publication number: 20190125643Abstract: The present invention relates to an anti-aging composition. More specifically, the anti-aging composition according to the present invention is highly stable, harmless to the body, and effective in reducing wrinkles and improving elasticity of the skin due to the superb capability for stimulating collagen biosynthesis.Type: ApplicationFiled: April 7, 2017Publication date: May 2, 2019Applicant: NEOPHARM CO., LTD.Inventors: Se Kyoo JEONG, Bu-Mahn PARK, Kyung Sook YOO, Sung Woo KIM, Hye Seong SHIN
-
Patent number: 10016351Abstract: The present invention relates to a composition for promoting hair growth or preventing hair loss and, specifically, to a composition, which has excellent stability for skin and no side effects, promotes hair growth, prevents hair loss through the delay of hair loss, and has an excellent hair growth effect.Type: GrantFiled: November 11, 2015Date of Patent: July 10, 2018Assignee: NEOPHARM CO., LTD.Inventors: Se Kyoo Jeong, Jong Hwan Bae, Bu Mahn Park, Dae Hwan Kim
-
Patent number: 9867776Abstract: Provided is a transdermal drug delivery system, which is a delivery system for transdermal absorption, having a multi-lamellar emulsion structure, including: lipids including long-chain amides, sterols, fatty acid and fatty alcohol; an emulsifier; oil; and at least one drug for transdermal administration. The transdermal drug delivery system in a multi-lamellar emulsion structure, according to the present invention, has a lamellar structure in which a layered structure visible in stratum corneum intercellular lipids of the human body is repeated, and thus has an excellent skin barrier effect and enables a drug to be effectively partitioned through skin lipids, thereby obtaining an excellent drug delivery effect.Type: GrantFiled: July 1, 2014Date of Patent: January 16, 2018Assignee: NEOPHARM CO., LTD.Inventors: Se Kyoo Jeong, Ji Yeon Park, Min Seok Kim, Jong Mi Lim
-
Patent number: 9796665Abstract: The present invention relates to a novel pseudoceramide derivative, a pharmaceutically acceptable salt thereof or a solvate thereof, and a pharmaceutical or cosmetic composition containing the same as an active ingredient. The novel pseudoceramide derivative of the present invention is expected to be very useful for treating or preventing skin diseases by activating cannabinoid receptors. In addition, the novel pseudoceramide derivative, the pharmaceutically acceptable salt thereof or the solvate thereof, of the present invention, has a simple synthesis process compared with a known cannabinoid receptor antagonist so as to reduce processing time and curtail material costs, and thus is economical, and has advantages such as easy emulsification during the formulation of cosmetic products or medical supplies.Type: GrantFiled: September 1, 2014Date of Patent: October 24, 2017Assignee: NEOPHARM CO., LTD.Inventors: Se Kyoo Jeong, Bong-Woo Kim, Jeong Eun Jeon, Bu-Mahn Park
-
Patent number: 9783489Abstract: The present invention relates to a pharmaceutical composition and a cosmetic composition, which contain, as an active ingredient, a novel pseudo compound having similar structural characteristics to natural ceramide 1, or a pharmaceutically acceptable salt or solvate thereof, and the composition containing the compound of the present invention as an active ingredient has an excellent effect of enhancing a skin barrier function, thereby exhibiting an effect of alleviating inflammatory skin diseases, and has an excellent skin barrier improving function and an excellent skin moisturization enhancing effect.Type: GrantFiled: December 23, 2014Date of Patent: October 10, 2017Assignee: NEOPHARM CO., LTD.Inventors: Se Kyoo Jeong, Bong Woo Kim, Bu Mahn Park, Jeong Eun Jeon, Byung Gee Kim
-
Patent number: 9744243Abstract: The composition of external application to the skin according to the present invention may specifically control the relative amount between long-chain amides and sterols and the relative amount between lipid components and an emulsifier in the emulsion having a multi-layered lamella structure, the emulsion comprising a relatively larger content of dermatologically useful hydrophobic material in a formulation. Thus, the formulation having significantly high stability and excellent characteristics can be obtained in spite of the high content in the lipid components and the emulsifier.Type: GrantFiled: November 29, 2013Date of Patent: August 29, 2017Assignee: NEOPHARM CO., LTD.Inventors: Shin-Hee Lee, Yoon Kim, Su-Hwan Kim, Byeong-Deog Park
-
Publication number: 20160367475Abstract: Provided is a transdermal drug delivery system, which is a delivery system for transdermal absorption, having a multi-lamellar emulsion structure, including: lipids including long-chain amides, sterols, fatty acid and fatty alcohol; an emulsifier; oil; and at least one drug for transdermal administration. The transdermal drug delivery system in a multi-lamellar emulsion structure, according to the present invention, has a lamellar structure in which a layered structure visible in stratum corneum intercellular lipids of the human body is repeated, and thus has an excellent skin barrier effect and enables a drug to be effectively partitioned through skin lipids, thereby obtaining an excellent drug delivery effect.Type: ApplicationFiled: July 1, 2014Publication date: December 22, 2016Applicant: NEOPHARM CO., LTD.Inventors: Se Kyoo JEONG, Ji Yeon PARK, Min Seok KIM, Jong Mi LIM
-
Publication number: 20160354293Abstract: The present invention relates to a composition for promoting hair growth, preventing hair loss, or relieving inflammation, and more specifically, to a composition which has excellent stability to the skin, has no side effects, and exhibits excellent effects of hair growth promotion and hair loss prevention by promoting hair growth and delaying hair loss. The composition according to the present invention contains a material belonging to a ceramidase inhibitor, glycol, C1-C5 lower alcohol, and water, and thus the composition is safe, has no side effects, can be continuously used for a long period of time, has an excellent effect of hair growth promotion or hair loss prevention by significantly promoting hair growth, and exhibits an inflammation relieving effect as well as a hair growth promoting effect, additionally.Type: ApplicationFiled: January 27, 2015Publication date: December 8, 2016Applicant: NEOPHARM CO., LTD.Inventors: Se Kyoo JEONG, Jong Hwan BAE, Bu Mahn PARK
-
Patent number: 9512220Abstract: The present invention relates to antibodies against angiopoietins 1 and 2, and derivatives of these antibodies. More specifically, the present invention relates to therapeutic use of the antibodies and fragment thereof which specifically bind to angiopoietins 1 and 2.Type: GrantFiled: April 5, 2011Date of Patent: December 6, 2016Assignee: NEOPHARM CO., LTD.Inventors: Eunkyung Lee, Hyunjung Kang, Minhee Kim, Eun hye Park
-
Publication number: 20160272578Abstract: The present invention relates to a novel pseudoceramide derivative, a pharmaceutically acceptable salt thereof or a solvate thereof, and a pharmaceutical or cosmetic composition containing the same as an active ingredient. The novel pseudoceramide derivative of the present invention is expected to be very useful for treating or preventing skin diseases by activating cannabinoid receptors. In addition, the novel pseudoceramide derivative, the pharmaceutically acceptable salt thereof or the solvate thereof, of the present invention, has a simple synthesis process compared with a known cannabinoid receptor antagonist so as to reduce processing time and curtail material costs, and thus is economical, and has advantages such as easy emulsification during the formulation of cosmetic products or medical supplies.Type: ApplicationFiled: September 1, 2014Publication date: September 22, 2016Applicant: NEOPHARM CO., LTD.Inventors: Se Kyoo JEONG, Bong-Woo KIM, Jeong Eun JEON, Bu-Mahn PARK
-
Patent number: 9102732Abstract: Disclosed are immunological compositions and methods for reducing activity of glucagon signaling using antibodies against glucagon receptor.Type: GrantFiled: September 8, 2009Date of Patent: August 11, 2015Assignee: NEOPHARM CO., LTD.Inventors: Eunkyung Lee, Seong-Kyung Seo, Tae-Seong Kim